<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In search of potential prognostic markers, we analyzed a large series of tissues of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and samples of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> arising in the terrain of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> for TP53 gene mutations by direct sequencing of exons 5 to 9 of the TP53 gene </plain></SENT>
<SENT sid="1" pm="."><plain>While 9 of 21 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> tested (42.9%) contained a TP53 mutation, none of 24 samples from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> were mutated </plain></SENT>
<SENT sid="2" pm="."><plain>This observation suggests that TP53 gene mutation may be a relatively late event in the progression from nondysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of esophagus </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, TP53 gene mutations alone are not likely to represent a widely useful prognostic marker of the risk of progression to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, at least not in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>